Advanced Wound Care Dressing Market

The advanced wound care dressing market is projected to expand from US$ 4.81 billion in 2024 to US$ 6.99 billion by 2031, with an estimated CAGR of 5.46% from 2031 to 2031.

Analyst's Perspective

The analysis of the advanced wound care dressing market highlights factors such as the rising incidence of burn injuries, chronic illnesses, and road traffic accidents, which lead to an increased demand for surgical interventions. This surge in surgical procedures subsequently drives the need for advanced wound care products. Additionally, technological advancements and new product introductions by industry players are anticipated to create fresh trends in the advanced wound care dressing market from 2022 to 2030. The market is categorized by type into foam dressing, alginate dressing, hydrogel dressing, hydrocolloid dressing, collagen dressing, film dressing, and others, with foam dressing holding the largest market share in 2022.

Advanced wound dressings are engineered to exhibit biological activity, either independently or through the release of drugs embedded within the dressing. These drugs can actively contribute to the wound healing process by either directly eliminating necrotic tissue or indirectly preventing or treating infections to facilitate tissue regeneration. Semi-permeable films and foams are classified as semi-occlusive, while hydrocolloids and hydrogels are recognized as advanced interactive dressings. These dressings enhance wound management by delivering medications to the wound site in a controlled manner, thereby improving treatment adherence and therapeutic results.

Market Insights

Growth of the Advanced Wound Care Dressing Market

The rising prevalence of chronic diseases such as ulcerative colitis, cardiac arrest, cancer, and brain hemorrhage has led to an increased demand for surgical procedures. For example, the Australian Institute of Health and Welfare (AIHW) reported that in 2020-2021, cardiovascular disease accounted for 600,000 hospitalizations, representing 5.1% of all hospital admissions in Australia. Among these, 146,000 coronary angiography procedures were performed, with 67% on males and 33% on females. Similarly, a 2023 Eurostats article indicated that transluminal coronary angioplasty was among the top ten surgical procedures in Europe, averaging 553 and 390 procedures per 100,000 inhabitants in Croatia and Germany, respectively.

Moreover, the increasing incidence of cancer, which often necessitates surgical tumor removal, poses a significant global health challenge. According to the National Center for Health Statistics (NCHS), in 2023, cancer caused 609,820 deaths and 1,958,310 new cases in the US. Additionally, surgical interventions for burns, scalds, and cosmetic plastic surgeries are contributing to the growth of the advanced wound care market. The International Society of Aesthetic Plastic Surgery (ISAPS) reported over 12.8 million surgical procedures performed by plastic surgeons in 2021, marking a 19.3% increase. Surgical procedures, including cardiac and plastic surgeries, result in surgical wounds and scarring. While most surgical wounds heal without complications, some may become infected post-surgery due to bacterial growth, delaying healing. Dressings used in surgeries aim to absorb fluids from the wound, create optimal healing conditions, and protect the area during recovery. Advanced wound dressings like foam and hydrogel dressings have proven effective in accelerating healing due to their antibacterial properties.

Future Trends

Technological Advancements Shaping the Future of Advanced Wound Care Dressing Market

Leading companies in the advanced wound care dressing market are prioritizing research and development, resulting in the launch of innovative products that outperform traditional dressings. In March 2022, Cardinal Health introduced its first surgical incise drape featuring the industry-leading antiseptic chlorhexidine gluconate (CHG). This drape utilizes Avery Dennison's patented BeneHold CHG adhesive technology to minimize the risk of surgical site contamination by inhibiting the growth of organisms that typically cause surgical site infections (SSIs). The incise film is durable, adaptable, and breathable, providing a sterile barrier against contamination.

In April 2023, Convatec Group Plc acquired the anti-infective nitric oxide technology platform from 30 Technology Limited. Beyond its application in advanced wound care, Convatec aims to explore this innovative technology across all its business sectors, enhancing its advanced wound care offerings.

Coloplast has made significant strides in wound care innovation, with the Biatain silicone foam dressing noted for its superior absorption and minimal maceration risk. The company also provides a variety of products for complex wound management, including Comfeel Plus pressure ulcer dressings and SenSura Mio Convex Flex ostomy appliances. Such product innovations encourage healthcare providers to transition from traditional to advanced dressings, likely propelling the growth of the advanced wound care dressing market.

Strategic Insights

Report Segmentation and Scope

Type-Based Insights

The advanced wound care dressing market is categorized by type into foam dressing, alginate dressing, hydrogel dressing, hydrocolloid dressing, collagen dressing, film dressing, and others. The foam dressing segment dominated the market in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030. Foam dressings are absorbent, non-linting, and available in various thicknesses, featuring a non-adherent layer for gentle removal without trauma. Some foam dressings include an adhesive border and a film coating for added bacterial protection. They maintain a moist environment and insulation for the wound and are available as pads, sheets, and pillow (cavity) dressings. Foam dressings can serve as primary or secondary dressings for partial and full-thickness wounds with varying drainage levels and can also absorb drainage around tubes. These characteristics make foam dressings particularly suitable for chronic wounds, facilitating rapid and effective healing treatment.

Application-Based Insights

The advanced wound care dressing market is segmented by application into heavy exudated wounds, burns and scalds, ulcers/bedsores/cavity wounds, post-operative wounds and injuries, and others. The heavy exudated wounds segment held the largest market share in 2022 and is projected to register the highest CAGR from 2022 to 2030.

End User-Based Insights

By end user, the advanced wound care dressing market is divided into hospitals & clinics, specialty centers, homecare, and others. The hospitals & clinics segment accounted for the largest market share in 2022 and is expected to achieve the highest CAGR from 2022 to 2030.

Advanced Wound Care Dressing Market Report Scope

Regional Analysis

The North American advanced wound care dressing market includes the US, Canada, and Mexico. The growth in this market is driven by the increasing number of acquisitions by leading market players in the region. The US advanced wound care dressing market is anticipated to experience significant growth due to rapid technological advancements and rising healthcare expenditures.

The report profiles key players in the global advanced wound care dressing market, including TRIAGEMEDITECH Pvt. Ltd; Convatec Group PLC; MedSupply Inc.; Smith and Nephew; HARTMANN USA, Inc.; Medtronic; Medical Monks; 3M; Molnlycke Health Care AB; Coloplast Corp; and MEDCU.

• In August 2022, 3M Health Care's Medical Solutions Division launched an advanced version of 3M Veraflo Therapy, featuring a new 3M Veraflo Cleanse Choice Complete Dressing Kit and a software upgrade for the 3M V.A.C. Ulta Therapy Unit, available to customers at no extra cost. These enhancements streamline care delivery for clinicians using Veraflo Therapy, a negative pressure wound therapy with instillation, making dressing changes quicker, easier, and less painful for patients compared to previous Veraflo Therapy dressings.
• In January 2022, Convatec Group Plc finalized an agreement to acquire Triad Life Sciences Inc., a US-based medical device company focused on developing biologically-derived innovative products for managing surgical wounds, chronic wounds, and burns. The acquisition was completed in Q1 2022, pending regulatory approvals and customary conditions.